| Age, years ± SD | 39±13 |
| Female, n (%) | 67 (90%) |
| Hispanic, n (%) | 56 (77%) |
| African American, n (%) | 14 (19%) |
| Body mass index | 30±8.3 |
| Median Disease Duration, years (IQR) | 6.5 (4–12) |
| Median SLEDAI (IQR) | 4 (2–8) |
| Moderate-Severe Disease activity (SLEDAI ≥6), n (%) | 23 (31%) |
| Median SDI, n (%) | 0 (0–1) |
| hsCRP median (IQR) | 2.4 (1–6.5) |
| ESR , Median (IQR) | 37 (23–51) |
| Anti-DNA, n (%) | 44 (60%) |
| Anti-SSA, n (%) | 42 (59%) |
| Anti-Smith, n (%) | 21 (30%) |
| Ever smoker, n (%) | 16 (22%) |
| Hypertension, n (%) | 22 (30%) |
| Diabetes, n (%) | 6 (8%) |
| mFRS, median (IQR) | 0.5 (0–1.8) |
| NST-T abnormalities, n (%) | 27 (38%) |